It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Papillary renal cell carcinoma (pRCC) is the most heterogenous renal cell carcinoma. Patient survival varies and no effective therapies for advanced pRCC exist. Histological and molecular characterization studies have highlighted the heterogeneity of pRCC tumours. Recent studies identified the proximal tubule (PT) cell as a cell-of-origin for pRCC. However, it remains elusive whether other pRCC subtypes have different cell-of-origin. Here, by obtaining genome-wide chromatin accessibility profiles of normal human kidney cells using single-cell transposase-accessible chromatin-sequencing and comparing the profiles with pRCC samples, we discover that besides PT cells, pRCC can also originate from kidney collecting duct principal cells. We show pRCCs with different cell-of-origin exhibit different molecular characteristics and clinical behaviors. Further, metabolic reprogramming appears to mediate the progression of pRCC to the advanced state. Here, our results suggest that determining cell-of-origin and monitoring origin-dependent metabolism could potentially be useful for early diagnosis and treatment of pRCC.
The heterogeneity of cell-of-origin for papillary renal cell carcinoma (pRCC) remains unknown. Here, with single-cell ATAC-seq from normal human kidney cells and ATACseq profiles from pRCC samples, the authors show that pRCC can originate from kidney collecting duct principal cells and this subtype is associated with advanced pRCC.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Medical School of Nanjing University, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
2 Medical School of Nanjing University, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Medical School of Nanjing University, National Clinical Research Center for Kidney Disease, Jinling Hospital, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
3 School of Computer Science, Nanjing University of Posts and Telecommunications, Nanjing, China (GRID:grid.453246.2) (ISNI:0000 0004 0369 3615)
4 Medical School of Nanjing University, Department of Pathology, Affiliated Drum Tower Hospital, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
5 Medical School of Nanjing University, Department of Urology, Affiliated Drum Tower Hospital, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
6 Medical School of Nanjing University, National Clinical Research Center for Kidney Disease, Jinling Hospital, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
7 Emory University, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
8 Medical School of Nanjing University, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Medical School of Nanjing University, National Clinical Research Center for Kidney Disease, Jinling Hospital, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)